Navigation Links
When our skin fails to protect us
Date:3/20/2012

The skin is the body's largest organ and an indispensable part of the immune system. As the body's outermost line of defense against microbes, the skin provides important protection against potentially toxic environmental elements. One subset of immune cells, thymus-derived T-cells play an important role in the skin's response to injury, particularly with respect to wound healing. When epidermal T-cells do not respond effectively, non-healing wounds may result. The treatment of chronic wounds is the single most important contributor to skin-related health care costs in the elderly. Professor Thomas Krieg, Dean of the Medical Faculty and Principal Investigator in the Cluster of Excellence for Cellular Stress Responses in Aging-Associated Diseases (CECAD) at the University of Cologne, Germany, will address issues and treatments of chronic wounds, which are a challenge to patients and aging societies as a whole. Prof. Krieg's research at the University of Cologne's department of dermatology includes cell-cell and cell-extracellular matrix interactions as crucial components for the maintenance of healthy skin functions.

T-cells are also involved in the development of a wide range of autoimmune disorders that affect the skin and hair. Alopecia Areata, for example, is an organ-specific autoimmune disease in which T-cells attack human hair follicles and damage them with resulting hair loss. Dr. Angela Christiano, Richard and Mildred Rhodebeck Professor of Dermatology and Professor of Genetics & Development at Columbia University Medical Center, will discuss Alopecia Areata. Her major focus of research is the study of inherited skin and hair disorders in humans, through a classical genetic approach that include identification and phenotyping of disease families, genetic linkage, gene discovery and mutation analysis, and most recently, functional studies relating these findings to basic questions in epidermal biology.

Dr. David Bickers, Carl Truman Ne
'/>"/>

Contact: Andrea Deierlein
deierlein@germaninnovation.org
212-339-8606
German Center for Research and Innovation
Source:Eurekalert

Page: 1 2

Related biology news :

1. When standard treatment fails: Jefferson to start unique immunotherapy for brain tumor patients
2. Sight fails when defective eye cells cripple renewal
3. MS study offers theory for why repair of brains wiring fails
4. Marine Protected Areas are keeping turtles safe
5. Building the European Unions Natura 2000 -- the largest ever network of protected areas
6. Improved Authentication and Confidentiality Protection. ICAP Patent Brokerage Announces for Auction Important Patents in Data Encryption and Document Security
7. Rising ocean temperatures harm protected coral reefs
8. Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection
9. New study will help protect vulnerable birds from impacts of climate change
10. Protecting living fossil trees
11. Study IDs new marine protected areas in Madagascar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2015)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2015.  ... a decrease of 33% compared to $6.8 million in the ... of 2015 was $0.3 million, or $0.01 per diluted share, ... in the same period a year ago.  ...
(Date:7/20/2015)...  Acuity Market Intelligence,s latest research "The Global ... and Privacy" forecasts that between 2014 and 2020 ... downloaded to smart mobile devices by 2.2 billion ... projected to generate more than $67.9 billion in ... period.    "Biometrics is at the ...
(Date:7/9/2015)... PLEASANTON, Calif. , July 9, 2015 /PRNewswire/ ... tools, today announcing its acquisition of Avid Nano. ... dynamic light scattering (DLS) systems.    ... world,s smallest, fastest and easiest to use protein ... system that measures a protein,s hydrodynamic size, size ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... Cold Spring Harbor, NY A team of researchers at ... of DNA called an enhancer element that enables cancerous blood ... cancer that is incurable in 70% of patients. Just ... a new class of promising drugs one version of ...
... Calif. John Trumble , a distinguished professor ... Riverside, has been named the recipient of the 2013 ... and/or extension education benefiting the California vegetable industry. ... problems in agricultural and natural ecosystems, will receive the ...
... in the form of humidity, water spills, or rainfall ... displays, TVs, and solar photovoltaic (PV) panels worldwide. Standing ... a transparent film barrier that must work flawlessly year after ... test that can detect infinitesimally small amounts of moisture ...
Cached Biology News:Scientists discover how leukemia cells exploit 'enhancer' DNA elements to cause lethal disease 2Scientists discover how leukemia cells exploit 'enhancer' DNA elements to cause lethal disease 3Entomologist recognized for exceptional service to California's vegetable industry 2NREL test helps make moisture barriers better 2NREL test helps make moisture barriers better 3NREL test helps make moisture barriers better 4NREL test helps make moisture barriers better 5NREL test helps make moisture barriers better 6NREL test helps make moisture barriers better 7
(Date:7/29/2015)... NJ (PRWEB) , ... July 29, 2015 , ... The ... approval of combination products , in particular, drug/device combinations. The current system received ... by the Initiative for Patient Centered Innovation (iPCI) of Fairleigh Dickinson University’s ...
(Date:7/29/2015)... ... 29, 2015 , ... Available in select spas and ... nighttime-specific product that targets fat cells for extreme contouring action. During sleep key ... cells, inhibiting the formation of new fat. Upon waking CHRONODIET breaks down fat ...
(Date:7/28/2015)... -- A n ew ... developing and commercialising innovative medicines to transform patient quality of ... experienced management team; blue chip ... BioPharma Group Ltd ("Mereo"), a recently-formed speciality biopharmaceutical company, announces ... gross, from blue chip institutional investors and simultaneously acquired a ...
(Date:7/28/2015)... Mass. , July 28, 2015 ... measuring cell metabolism, is the provider of XF ... across all disease research areas. As the links ... exploration into cell metabolism is escalating rapidly.   ... published by the Nature Publishing Group (NPG) featuring ...
Breaking Biology Technology:Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 2XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 3
... Imaging and Printing Group and its Personal Systems Group into ... milestone in HPs journey to become the consumer ... a unified and convincing product message for every room in ... HPs consumer message into overdrive. , ,The consumer technology market ...
... Merge Technologies Incorporated and Cedara Software Corp. ... develop health-care software, particularly digital medical imaging. , ,Pending stockholder ... in Milwaukee. Merge CEO Richard Linden will stay ... Abe Schwartz will stay on the board of directors. Merge ...
... an idea of what Madison could offer to the field ... how many new visitors our coverage of last Thursday's ... WTN 's Web site. Our normal recurring readership is ... than half are from out-of-state and about 15 percent read ...
Cached Biology Technology:HP charges toward the living room 2HP charges toward the living room 3International eyes drawn to Madison's games research 2International eyes drawn to Madison's games research 3International eyes drawn to Madison's games research 4
... , Coated Capture Antibody: 12 x 8-well strips, ... mL of 2X concentrate , Beta Amyloid ... , Lyophilized Standard Diluent: 3 mL , Primary ... Antibody-HRP: 30 microL of concentrate , OPD Substrate: ...
Human Cell Line Slides...
Request Info...
HSV 1 IgM...
Biology Products: